Hepatic glucose regulation and metabolism in adult sheep: effects of prenatal betamethasone.
Fetal exposure to synthetic glucocorticoids in sheep results in increased fetal hepatic 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) and corticosteroid-binding globulin (CBG) protein levels and insulin resistance in postnatal life. The aim was to determine whether these changes persisted to adulthood and whether alterations in mediators of hepatic glucocorticoid and glucose regulation contributed to changes in metabolism. Pregnant ewes or their fetuses received either repeated intramuscular saline (MS, FS) or betamethasone injections (0.5 mg/kg; M4, F4) at 104, 111, 118, and 124 days of gestation (dG), or a single betamethasone injection at 104 dG followed by saline at 111, 118, and 124 dG (M1, F1). Offspring were catheterized at 2 and 3 yr of age and given an intravenous glucose challenge (0.5 mg/kg). Hepatic tissue was collected at 3.5 yr. At 2 yr of age, basal plasma insulin was elevated in M4 offspring and at 3 yr of age was elevated in F4 offspring. Basal insulin-to-glucose ratio was significantly elevated in M4 offspring at 2 yr of age and elevated in M1, M4, and F4 offspring at 3 yr of age. All betamethasone treatments resulted in significant increases in hepatic glucose-6-phosphatase (G-6-Pase) activity. Hepatic glucocorticoid receptor protein levels were not altered in M1 and M4 offspring but were increased in F1 and F4 offspring. Hepatic CBG protein levels were lower in F4 but not F1 offspring and were unchanged from control in M1 and M4 offspring. Prenatal betamethasone exposure results in elevated hepatic G-6-Pase activity in adulthood and may contribute to long-term changes in metabolism.
Sloboda
Deborah M
DM
School of Women's and Infants' Health, University of Western Australia, Perth, Australia. dsloboda@obsgyn.uwa.edu.au
Moss
Timothy J M
TJ
Li
Shaofu
S
Doherty
Dorota A
DA
Nitsos
Ilias
I
Challis
John R G
JR
Newnham
John P
JP
D000818:Animals; D001623:Betamethasone / Q000008:administration & dosage*; D001786:Blood Glucose / Q000378:metabolism*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D007273:Injections, Intramuscular; D007328:Insulin / Q000097:blood*; D008099:Liver / Q000187:drug effects / Q000196:embryology* / Q000378:metabolism*; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D012756:Sheep
D001786:Blood Glucose; D005938:Glucocorticoids; D007328:Insulin; D001623:Betamethasone